FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Cowen lowered its price target on Evolent Health (NYSE: EVH) to $33.00 (from $35.00) while maintaining a Outperform rating following 2Q release. Reported revenues of $107.3M exceeded guidance, and consensus estimates, despite soft transformation sales. Adjusted EPS of ($0.13) was in-line with Street's expectations.
EVH... More

